TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9893656

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 320 mg/day (two 160 mg tablets/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 8017124

Group type: EXPERIMENTAL
Intervention: Dried preparation of bifidumbacterin administered for 4-6 days
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Dried preparation of bifidumbacterin
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 225
Study: 2681838

Group type: EXPERIMENTAL
Intervention: Indomethacin suppository (50 to 100 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 476300

Group type: EXPERIMENTAL
Intervention: Prophylactic granulocyte transfusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Platelet transfusion alone
Number of subjects: 19
Study: 30632656

Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 27906800

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 10⁸ CFU daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 25864240

Group type: EXPERIMENTAL
Intervention: 10% nHAP toothpaste
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 15% nHAP toothpaste
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NovaMin toothpaste
Number of subjects: 80

Group type: COMPARATOR
Intervention: Na-MFP toothpaste
Number of subjects: 80
Study: 24063578

Group type: EXPERIMENTAL
Intervention: Surgical treatment including Lugol's iodine staining
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard surgical treatment arm
Number of subjects: 300
Study: 21133820

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 41
Study: 19215190

Group type: EXPERIMENTAL
Intervention: XELOX (capecitabine/oxaliplatin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFOX6 (5Fluorouracil/leucovorin/oxaliplatin)
Number of subjects: 0
Study: 17234518

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Azathioprine (Aza)
Number of subjects: 190
Study: 12902895

Group type: EXPERIMENTAL
Intervention: Intravesical chemotherapy
Number of subjects: 2261

Group type: COMPARATOR
Intervention: BCG immunotherapy
Number of subjects: 2261
Study: 10518847

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS) at total daily doses of 0.25 mg, 0.5 mg, 1.0 mg, and 2.0 mg
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS)
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Conventional asthma therapy (CAT)
Number of subjects: 1017
Study: 7567406

Group type: EXPERIMENTAL
Intervention: Exercise (Harvard Step Test)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Inactive period (Control)
Number of subjects: 65
Study: 1837606

Group type: EXPERIMENTAL
Intervention: Intensive dynamic back extensor exercises (30 sessions over 3 months)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Alternative group (1/5 of the treatment group's exercise program per session)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Alternative group (thermotherapy, massage, and mild exercise)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Treatment group (completed training at least once a week for 1 year)
Number of subjects: 105
Study: 7019266

Group type: EXPERIMENTAL
Intervention: 0.1% stannous fluoride (SnF2), rinsed twice daily for 5 days
Number of subjects: 4

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine digluconate, rinsed twice daily for 5 days after SnF2
Number of subjects: 4
Study: 28844651

Group type: EXPERIMENTAL
Intervention: Raising vowel formant frequencies (FFs) for vowels /ɑ/ and /æ/
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raising FFs for all four vowels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual analysis of vowels and formants
Number of subjects: 0
Study: 27508917

Group type: EXPERIMENTAL
Intervention: Personalized and telephone nursing counseling for 7 months (Intervention group)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Traditional consultation plus personalized and telephone nursing counseling for 7 months (Intervention group)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 109
Study: 24376067

Group type: EXPERIMENTAL
Intervention: Structured practice group (SPG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Unstructured practice group (UPG)
Number of subjects: 22
Study: 22885649

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 13

Group type: COMPARATOR
Intervention: PS
Number of subjects: 13
Study: 20117965

Group type: EXPERIMENTAL
Intervention: PBPCT
Number of subjects: 329

Group type: COMPARATOR
Intervention: BMT
Number of subjects: 329
Study: 18377231

Group type: EXPERIMENTAL
Intervention: Ear points' pressing at 5 ear meridian points
Number of subjects: 38

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 38
Study: 15948743

Group type: EXPERIMENTAL
Intervention: BCG (81 mg Connaught strain)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Epirubicin (50 mg)
Number of subjects: 209
Study: 11837383

Group type: EXPERIMENTAL
Intervention: Moexipril 15 mg single oral dose in fasting state
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Moexipril 15 mg single oral dose in postprandial state
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Moexipril 15 mg single oral dose
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Moexipril 15 mg once daily for 5 days
Number of subjects: 100
Study: 10445897

Group type: EXPERIMENTAL
Intervention: Treatment group with access to case management and community care benefits (up to $699 per month)
Number of subjects: 5307

Group type: COMPARATOR
Intervention: Control group (no access to case management or community care benefits)
Number of subjects: 5307
Study: 8665543

Group type: EXPERIMENTAL
Intervention: 2 x 5 mg selegeline
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 x 10 mg selegeline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1706014

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 300 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Enalapril 20 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combination therapy (enalapril 20 mg + sustained-release diltiazem 300 mg)
Number of subjects: 96
Study: 6944548

Group type: EXPERIMENTAL
Intervention: Adjuvant ovarian ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30610862

Group type: EXPERIMENTAL
Intervention: FMTv (Fecal Microbiota Transplantation after 4-10 days of vancomycin 125 mg 4 times daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: fidaxomicin (200 mg twice daily for 10 days)
Number of subjects: 64

Group type: COMPARATOR
Intervention: vancomycin (125 mg 4 times daily for 10 days)
Number of subjects: 64
Study: 28751244

Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 0
Study: 25051005

Group type: EXPERIMENTAL
Intervention: Resistance exercise (3 times a week, in the afternoon, 6‐7 repetitions, at 85% of 1 repetition maximum for 3 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise during the 3 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 20
Study: 23512093

Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training (hi-IMT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham inspiratory muscle training (sham-IMT)
Number of subjects: 22
Study: 21874947

Group type: EXPERIMENTAL
Intervention: mini-midvastus (MV) approach
Number of subjects: 61

Group type: COMPARATOR
Intervention: mini-parapatellar approach
Number of subjects: 61

Group type: COMPARATOR
Intervention: standard parapatellar approach
Number of subjects: 61

Group type: COMPARATOR
Intervention: mini-subvastus approach
Number of subjects: 61
Study: 19819004

Group type: EXPERIMENTAL
Intervention: Modified killed-whole-cell cholera vaccine
Number of subjects: 107774

Group type: COMPARATOR
Intervention: Heat-killed Escherichia coli K12 placebo
Number of subjects: 107774
Study: 17101886

Group type: EXPERIMENTAL
Intervention: Active 10‐Hz rTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 22
Study: 14508197

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy
Number of subjects: 10
Study: 10811079

Group type: EXPERIMENTAL
Intervention: Vigabatrin monotherapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Carbamazepine monotherapy
Number of subjects: 32
Study: 8968432

Group type: EXPERIMENTAL
Intervention: Combination therapy of hydrochlorothiazide, atenolol, captopril, diltiazem‐SR, clonidine, and prazosin
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Prazosin after diltiazem
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Diltiazem after prazosin
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Captopril-diltiazem
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Diltiazem-captopril
Number of subjects: 102
Study: 1319735

Group type: EXPERIMENTAL
Intervention: L (80 mg/day lovastatin)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: L + GG (80 mg/day lovastatin + 20 g/day guar gum)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: L + C (80 mg/day lovastatin + 16 g/day cholestyramine)
Number of subjects: 62
Study: 6381570

Group type: EXPERIMENTAL
Intervention: Alert group
Number of subjects: 396

Group type: COMPARATOR
Intervention: Nonalert group
Number of subjects: 396
Study: 30951267

Group type: EXPERIMENTAL
Intervention: Treating early, intensively and to target (specific treatment details not provided)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Rapid and persistent disease control
Number of subjects: 333

Group type: COMPARATOR
Intervention: Treatment type (not specified)
Number of subjects: 333
Study: 28328346

Group type: EXPERIMENTAL
Intervention: Live, oral bovine rotavirus pentavalent vaccine (BRV-PV)
Number of subjects: 3508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3508
Study: 26336050

Group type: EXPERIMENTAL
Intervention: LUTS intervention group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 31
Study: 23515453

Group type: EXPERIMENTAL
Intervention: Org 43553 (25-900 mg)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Org 43902 (30-300 mg)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo (not specified)
Number of subjects: 159
Study: 20980485

Group type: COMPARATOR
Intervention: Serum concentrations of 25(OH)D ≥ 30 ng/mL
Number of subjects: 3085

Group type: EXPERIMENTAL
Intervention: Dietary vitamin D intake (for premenopausal women)
Number of subjects: 3085
Study: 19803572

Group type: EXPERIMENTAL
Intervention: Battlemind debriefing
Number of subjects: 2297

Group type: EXPERIMENTAL
Intervention: Small group Battlemind training
Number of subjects: 2297

Group type: EXPERIMENTAL
Intervention: Large group Battlemind training
Number of subjects: 2297

Group type: COMPARATOR
Intervention: Stress education
Number of subjects: 2297
Study: 17081209

Group type: EXPERIMENTAL
Intervention: Repeat ablation after CPVA
Number of subjects: 47
Study: 14991627

Group type: EXPERIMENTAL
Intervention: D1 surgery
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: D3 surgery
Number of subjects: 221
Study: 11703423

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 30
Study: 9826140

Group type: EXPERIMENTAL
Intervention: y-axis inverted imaging conditions
Number of subjects: 22

Group type: COMPARATOR
Intervention: normal imaging conditions
Number of subjects: 22
Study: 8085125

Group type: EXPERIMENTAL
Intervention: 1% glucose solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10% glucose solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50% glucose solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no glucose solution)
Number of subjects: 10
Study: 2713604

Group type: EXPERIMENTAL
Intervention: Silk tube
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard tube
Number of subjects: 70
Study: 1067480

Group type: COMPARATOR
Intervention: Maintenance therapy with 6 mercaptopurine (6 MP) and methotrexate (MTX)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with 6 mercaptopurine (6 MP), methotrexate (MTX) and cyclophosphamide (Cyclo)
Number of subjects: 129

Group type: COMPARATOR
Intervention: CNS prophylaxis with cranial radiation (2500 rad) and intrathecal administration of methotrexate (MTX) and prednisolone
Number of subjects: 129

Group type: COMPARATOR
Intervention: Overall treatment including induction therapy with vincristine (VCR) and prednisone (Pred)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Overall treatment including maintenance therapy
Number of subjects: 129
Study: 31274491

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 65
Study: 28379861

Group type: EXPERIMENTAL
Intervention: Extended-Release Injectable Naltrexone (XR-NTX) 380 mg, 6 monthly doses
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both XR-NTX and Placebo
Number of subjects: 100
Study: 24460005

Group type: EXPERIMENTAL
Intervention: Jump 10 group (10 jumps, twice daily for 16 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Jump 20 group (20 jumps, twice daily for 16 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 23411791

Group type: EXPERIMENTAL
Intervention: Whole body vibration training combined with conventional physical therapy training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physical therapy training
Number of subjects: 30
Study: 21562064

Group type: EXPERIMENTAL
Intervention: Saxagliptin 2.5 mg
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg
Number of subjects: 565

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study: 19223559

Group type: COMPARATOR
Intervention: HPV 16/18 infection
Number of subjects: 553

Group type: COMPARATOR
Intervention: Other HR-HPVs
Number of subjects: 553

Group type: COMPARATOR
Intervention: Persistent HPV 16/18 infection
Number of subjects: 553
Study: 16566621

Group type: EXPERIMENTAL
Intervention: Lamotrigine 200 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15321054

Group type: EXPERIMENTAL
Intervention: Prompt beta brachytherapy (immediately after intervention, n=21)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Delayed beta brachytherapy (24 h later, n=18)
Number of subjects: 39
Study: 10357422

Group type: EXPERIMENTAL
Intervention: High resolution pulsed and color Doppler ultrasound
Number of subjects: 71
Study: 7594160

Group type: EXPERIMENTAL
Intervention: Neuropsychological tests including KOLT and retention on WLM and WVR
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: KOLT and retention on WLM and WVR
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wechsler's Logical Memory and Visual Reproduction tasks, Kendrick's Object Learning Test
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard mental status scales
Number of subjects: 60
Study: 1954080

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 micrograms, 3.5 x 10(‐7) M)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6165954

Group type: EXPERIMENTAL
Intervention: Midodrin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6142208

Group type: EXPERIMENTAL
Intervention: Artificial surfactant therapy (30 mg dipalmitoylphosphatidylcholine and 3 mg high-density lipoprotein in a 5 ml suspension)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no surfactant treatment)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Artificial surfactant therapy
Number of subjects: 100
Study: 29974563

Group type: EXPERIMENTAL
Intervention: CBT-based group counselling with HBCSS
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: HBCSS alone
Number of subjects: 532

Group type: COMPARATOR
Intervention: Self-help guidance-based group counselling (SHG)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 532
Study: 27417074

Group type: EXPERIMENTAL
Intervention: Brainwave music (BWM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 24661511

Group type: COMPARATOR
Intervention: Triple therapy (amoxicillin 40 mg/(kg·d), Tid; clarithromycin 15 mg/(kg·d), Bid; omeprazole 0.7-0.8 mg/(kg·d), Qd)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Triple therapy combined with Saccharomyces boulardii (250 mg, Bid)
Number of subjects: 240
Study: 23171757

Group type: EXPERIMENTAL
Intervention: Inactivated PCV2 vaccine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sterile PBS (control)
Number of subjects: 10
Study: 20601905

Group type: EXPERIMENTAL
Intervention: Probiotic and prebiotic fortified milk (1.9 x 10 colony-forming units of Bifidobacterium lactis HN019 and 2.4 g/day of prebiotic oligosaccharides)
Number of subjects: 624

Group type: COMPARATOR
Intervention: Control milk (non-fortified)
Number of subjects: 624
Study: 17568755

Group type: EXPERIMENTAL
Intervention: ETCare
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 60
Study: 15702140

Group type: EXPERIMENTAL
Intervention: TYR-free amino acid drink (74 g, lacking TYR and PHE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Balanced amino acid drink (BAL)
Number of subjects: 15
Study: 12093460

Group type: EXPERIMENTAL
Intervention: 19.6 g of arginine/d for 14 days (n = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo for 14 days (n = 5)
Number of subjects: 11
Study: 11225649

Group type: EXPERIMENTAL
Intervention: Niacin-bound chromium 200 microg t.i.d. for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo t.i.d. for 2 months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Niacin-bound chromium 600 microg daily for 2 months
Number of subjects: 20
Study: 7586602

Group type: EXPERIMENTAL
Intervention: Calculated dose group (131I dose based on thyroid gland type, accurate volume measurement, and 24-hour uptake determination)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Fixed dose group (fixed doses of 185, 370, or 555 MBq based on gland size assessment by palpation)
Number of subjects: 163
Study: 1778089

Group type: EXPERIMENTAL
Intervention: Phenothrin liquid shampoo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Carbaryl lotion
Number of subjects: 50
Study: 6118066

Group type: EXPERIMENTAL
Intervention: Antiparkinsonian group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 32
Study: 31434848

Group type: COMPARATOR
Intervention: 22-gauge conventional non-fenestrated catheter
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 24-gauge fenestrated catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: 22-gauge non-fenestrated catheter
Number of subjects: 50
Study: 30004570

Group type: EXPERIMENTAL
Intervention: PFNA treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: DHS internal fixation
Number of subjects: 80
Study: 26879224

Group type: EXPERIMENTAL
Intervention: Financial incentives for healthy groceries ($1 for every healthy food or beverage purchased)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Frequent coupon users (FCU)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-coupon users (NCU)
Number of subjects: 54
Study: 24837298

Group type: EXPERIMENTAL
Intervention: Proxy measures (care home staff reporting)
Number of subjects: 565
Study: 22517930

Group type: EXPERIMENTAL
Intervention: Hip resurfacing arthroplasty
Number of subjects: 126

Group type: COMPARATOR
Intervention: Total hip arthroplasty
Number of subjects: 126
Study: 19686276

Group type: EXPERIMENTAL
Intervention: 0.1% octenidine with 30% 1-propanol and 45% 2-propanol
Number of subjects: 400

Group type: COMPARATOR
Intervention: 74% ethanol with 10% 2-propanol
Number of subjects: 400
Study: 18035199

Group type: EXPERIMENTAL
Intervention: Erdosteine 225 mg BID and chest physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chest physiotherapy alone
Number of subjects: 30
Study: 16060740

Group type: EXPERIMENTAL
Intervention: High impression management individuals (Study 1)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High impression management individuals (Study 2)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High impression management African Americans (Study 3)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High impression management White students (Study 4)
Number of subjects: 4
Study: 12212411

Group type: EXPERIMENTAL
Intervention: Theater production 'All's Well That Eats Well'
Number of subjects: 4093
Study: 10490784

Group type: EXPERIMENTAL
Intervention: Low-energy diet for 2-5 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-energy diet after substantial weight loss
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-energy diet (early stages of weight loss)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Post substantial weight loss
Number of subjects: 10
Study: 7808487

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 623

Group type: COMPARATOR
Intervention: Intensive chemotherapy
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (both types)
Number of subjects: 623